208 related articles for article (PubMed ID: 35729616)
1. Epstein-Barr virus tegument protein BGLF2 in exosomes released from virus-producing cells facilitates de novo infection.
Sato Y; Yaguchi M; Okuno Y; Ishimaru H; Sagou K; Ozaki S; Suzuki T; Inagaki T; Umeda M; Watanabe T; Fujimuro M; Murata T; Kimura H
Cell Commun Signal; 2022 Jun; 20(1):95. PubMed ID: 35729616
[TBL] [Abstract][Full Text] [Related]
2. Suppression of JAK-STAT Signaling by Epstein-Barr Virus Tegument Protein BGLF2 through Recruitment of SHP1 Phosphatase and Promotion of STAT2 Degradation.
Jangra S; Bharti A; Lui WY; Chaudhary V; Botelho MG; Yuen KS; Jin DY
J Virol; 2021 Sep; 95(20):e0102721. PubMed ID: 34319780
[TBL] [Abstract][Full Text] [Related]
3. Epstein-Barr Virus (EBV) Tegument Protein BGLF2 Suppresses Type I Interferon Signaling To Promote EBV Reactivation.
Liu X; Sadaoka T; Krogmann T; Cohen JI
J Virol; 2020 May; 94(11):. PubMed ID: 32213613
[TBL] [Abstract][Full Text] [Related]
4. Epstein-Barr Virus (EBV) Tegument Protein BGLF2 Promotes EBV Reactivation through Activation of the p38 Mitogen-Activated Protein Kinase.
Liu X; Cohen JI
J Virol; 2016 Jan; 90(2):1129-38. PubMed ID: 26559845
[TBL] [Abstract][Full Text] [Related]
5. BGLF2 Increases Infectivity of Epstein-Barr Virus by Activating AP-1 upon
Konishi N; Narita Y; Hijioka F; Masud HMAA; Sato Y; Kimura H; Murata T
mSphere; 2018 Apr; 3(2):. PubMed ID: 29695622
[TBL] [Abstract][Full Text] [Related]
6. Epstein-Barr virus tegument protein BGLF2 inhibits NF-κB activity by preventing p65 Ser536 phosphorylation.
Chen T; Wang Y; Xu Z; Zou X; Wang P; Ou X; Li Y; Peng T; Chen D; Li M; Cai M
FASEB J; 2019 Sep; 33(9):10563-10576. PubMed ID: 31337264
[TBL] [Abstract][Full Text] [Related]
7. Epstein-Barr Virus BGLF2 commandeers RISC to interfere with cellular miRNA function.
Campbell AM; De La Cruz-Herrera CF; Marcon E; Greenblatt J; Frappier L
PLoS Pathog; 2022 Jan; 18(1):e1010235. PubMed ID: 35007297
[TBL] [Abstract][Full Text] [Related]
8. Modulation of B-cell exosome proteins by gamma herpesvirus infection.
Meckes DG; Gunawardena HP; Dekroon RM; Heaton PR; Edwards RH; Ozgur S; Griffith JD; Damania B; Raab-Traub N
Proc Natl Acad Sci U S A; 2013 Jul; 110(31):E2925-33. PubMed ID: 23818640
[TBL] [Abstract][Full Text] [Related]
9. Molecular Characterization of the Epstein-Barr Virus
Chen T; Zou X; Xu Z; Wang Y; Wang P; Peng H; Liu D; Lin J; Luo R; Wang Y; Chen Q; Chen D; Cai M; Li M
Iran J Biotechnol; 2018 May; 16(2):e1610. PubMed ID: 30805386
[TBL] [Abstract][Full Text] [Related]
10. Tegument proteins of Epstein-Barr virus: Diverse functions, complex networks, and oncogenesis.
Murata T
Tumour Virus Res; 2023 Jun; 15():200260. PubMed ID: 37169175
[TBL] [Abstract][Full Text] [Related]
11. Exosomes released in vitro from Epstein-Barr virus (EBV)-infected cells contain EBV-encoded latent phase mRNAs.
Canitano A; Venturi G; Borghi M; Ammendolia MG; Fais S
Cancer Lett; 2013 Sep; 337(2):193-9. PubMed ID: 23684926
[TBL] [Abstract][Full Text] [Related]
12. Cloning and characterization of cDNA clones corresponding to transcripts from the BamHI G region of the Epstein-Barr virus genome and expression of BGLF2.
Chen MR; Hsu TY; Lin SW; Chen JY; Yang CS
J Gen Virol; 1991 Dec; 72 ( Pt 12)():3047-55. PubMed ID: 1662696
[TBL] [Abstract][Full Text] [Related]
13. Epstein-Barr Virus BKRF4 Gene Product Is Required for Efficient Progeny Production.
Masud HMAA; Watanabe T; Yoshida M; Sato Y; Goshima F; Kimura H; Murata T
J Virol; 2017 Dec; 91(23):. PubMed ID: 28904200
[TBL] [Abstract][Full Text] [Related]
14. Multifunctional non-coding Epstein-Barr virus encoded RNAs (EBERs) contribute to viral pathogenesis.
Iwakiri D
Virus Res; 2016 Jan; 212():30-8. PubMed ID: 26292159
[TBL] [Abstract][Full Text] [Related]
15. Identification of herpesvirus proteins that contribute to G1/S arrest.
Paladino P; Marcon E; Greenblatt J; Frappier L
J Virol; 2014 Apr; 88(8):4480-92. PubMed ID: 24501404
[TBL] [Abstract][Full Text] [Related]
16. Viral miRNAs exploiting the endosomal-exosomal pathway for intercellular cross-talk and immune evasion.
Pegtel DM; van de Garde MD; Middeldorp JM
Biochim Biophys Acta; 2011; 1809(11-12):715-21. PubMed ID: 21855666
[TBL] [Abstract][Full Text] [Related]
17. Interaction Between BGLF2 and BBLF1 Is Required for the Efficient Production of Infectious Epstein-Barr Virus Particles.
Hung CH; Chiu YF; Wang WH; Chen LW; Chang PJ; Huang TY; Lin YJ; Tsai WJ; Yang CC
Front Microbiol; 2019; 10():3021. PubMed ID: 32038519
[TBL] [Abstract][Full Text] [Related]
18. TET2 functions as a resistance factor against DNA methylation acquisition during Epstein-Barr virus infection.
Namba-Fukuyo H; Funata S; Matsusaka K; Fukuyo M; Rahmutulla B; Mano Y; Fukayama M; Aburatani H; Kaneda A
Oncotarget; 2016 Dec; 7(49):81512-81526. PubMed ID: 27829228
[TBL] [Abstract][Full Text] [Related]
19. Epstein-Barr virus-encoded small RNAs (EBERs) are present in fractions related to exosomes released by EBV-transformed cells.
Ahmed W; Philip PS; Tariq S; Khan G
PLoS One; 2014; 9(6):e99163. PubMed ID: 24896633
[TBL] [Abstract][Full Text] [Related]
20. Functional Analysis of Exosomes Derived from EBV-Infected Cells.
Khan G; Philip PS
Methods Mol Biol; 2017; 1532():159-167. PubMed ID: 27873274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
